News Coverage 10.17.19 By: Frank Vinluan Share on Twitter Share on Facebook Share on LinkedIn ArsenalBio Launches With $85M for “Programmable” T Cell Therapies Related Announcement, Press Release Parker Institute for Cancer Immunotherapy Names Maria Olson Chief Advancement Officer Announcement, Press Release PICI Invests $1 Million+ in 5 Early Career Researchers Announcement, Patient Story Living Proof: Cancer Vaccine Recipients Bring Their Sto
Announcement, Press Release Parker Institute for Cancer Immunotherapy Names Maria Olson Chief Advancement Officer